BioCardia’s Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today
Biocardia Phase 3 CardiAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two Years
BioCardia Reports 2024 Business Highlights and Financial Results
BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025
BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System